Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
about
Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implicationsHepatic consequences of vascular adhesion protein-1 expressionVascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseasesDysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptakeChange in vascular adhesion protein-1 and metabolic phenotypes after vertical banded gastroplasty for morbid obesitySerum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetesAssociation between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidaseVascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisSerum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 DiabetesOrganic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread.Semicarbazide-sensitive amine oxidase and kidney disease.Ectoenzymes in leukocyte migration and their therapeutic potential.Vascular adhesion protein-1: Role in human pathology and application as a biomarker.Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.New actions of an old friend: perivascular adipose tissue's adrenergic mechanisms.Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase.Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?Perivascular Adipose Tissue's Impact on Norepinephrine-Induced Contraction of Mesenteric Resistance ArteriesVascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients.Vascular adhesion protein-1 and syndecan-1 in septic shock.Serum vascular adhesion protein-1 level is higher in smokers than non-smokers.A comparison between radiometric and fluorimetric methods for measuring SSAO activity.The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.Using gene expression to predict the secretome of differentiating human preadipocytes.Determination of Semicarbazide-Sensitive Amine Oxidase Activity in Blood Plasma by a Light Scattering Technique
P2860
Q24646745-B4E42430-AA5E-4D92-9833-FF2A7A4C612AQ28236182-E83E10CB-977C-4794-9198-9581F2E91B88Q28244962-E4307040-83B4-474C-BF58-F7DA66E649A7Q28250220-271D6A26-BD53-4268-9EFB-5B1D526C2BE3Q28253116-004B0392-95C2-46EC-8049-BB309669EC14Q28304388-9BFC4999-8AD3-4F7E-8D4E-4F8BF63CE547Q33619918-F3692CEB-4F5D-4778-8B7B-4253E1997526Q35056710-B4D8F359-9A05-43B0-B31C-B451BFB922D5Q35914428-B464A26F-E01D-4EC2-A67C-A6EC87D3F1D1Q36422420-CB134FFA-0C29-48E5-AE8B-3E7322A96FCAQ37868326-FC9B5F31-3356-454D-BCCD-B2FB38E09D7AQ38156644-62A58660-4399-40CB-9574-A1F872C97094Q38196724-736B9115-8FAE-4D86-90D3-AA93690C56C8Q38569377-C75E33F1-11C9-43C0-A8DA-5614E48BFC8BQ38622845-A0B82A2E-C104-4D8E-B13E-843778CC1366Q38835918-6F539936-C43D-4CCD-9543-AB01F3E5D806Q38853305-02CD6E6F-9521-4BDE-892F-4466E44506D0Q38998472-260570BC-0B83-4F8B-86CA-27FFC0D63999Q40239943-6DB60F31-15A9-446F-97FD-8440B8540448Q40309705-9B315878-D42D-429B-B1E3-72872331F670Q41558737-8AD33290-BC5E-4A28-A22A-C141F0EC6936Q41807882-6E50DD14-B8D0-45CA-B651-12DC7FDCEB84Q42686515-A4574D90-CA53-4743-B543-A0AB2EB67763Q45021935-176718C2-CE3A-4A40-B6C1-D28D5019941DQ46517140-65422FFD-138D-4853-9DF2-7E180CD1BA71Q46648427-6B37EA61-A605-447F-90FA-E4139A09D96AQ46923380-F3823412-571E-4001-B6A0-2723879A05F2Q48171413-3B1CA3A3-219B-4047-968C-F514A9FF610EQ51815748-6BC3A0A5-94A7-4A0E-AF9C-62C3422A7E0AQ58128681-E1D42D99-FB06-4472-A219-3B203E3D58BC
P2860
Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Adipocytes release a soluble f ...... ess and in a regulated manner.
@en
Adipocytes release a soluble f ...... ess and in a regulated manner.
@nl
type
label
Adipocytes release a soluble f ...... ess and in a regulated manner.
@en
Adipocytes release a soluble f ...... ess and in a regulated manner.
@nl
prefLabel
Adipocytes release a soluble f ...... ess and in a regulated manner.
@en
Adipocytes release a soluble f ...... ess and in a regulated manner.
@nl
P2093
P2860
P1433
P1476
Adipocytes release a soluble f ...... ess and in a regulated manner.
@en
P2093
A Ros-Baró
S García-Vicente
P2860
P2888
P304
P356
10.1007/S00125-004-1346-2
P577
2004-02-13T00:00:00Z